Handel nachbörslich: 102.26

Novartis AG ADR (NVS)

Novartis AG ADR Aktie (NVS) Neueste Nachrichten

Novartis AG ADR (NVS)

Novartis AG ADR Aktie (NVS) Neueste Nachrichten

MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'

Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss

2 Magnificent Dividend Stocks to Hold for the Next Decade

Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y

10 Sleep-Well-At-Night Dividend Aristocrats Perfect For Whatever's Coming Next

Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

16 High-Yield Dividend Aristocrats Yielding Almost 5%

Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates

Company News for Apr 24, 2024

Why Novartis Stock Topped the Market on Tuesday

Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?

Novartis Ag (NVS) Q1 2024 Earnings Call Transcript

Incyte (INCY) to Report Q1 Earnings: What's in the Cards?

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics

Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised

The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and Schlumberger

Wall Street Set To Open Higher As Tesla Kicks Off 'Magnificent 7' Earnings: Why This Analyst Thinks Market Weakness Is A 'Healthy Pullback'

Top Analyst Reports for Novartis, American Express & ConocoPhillips

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

Novartis (NVS) to Report Q1 Earnings: What to Expect?

Exploring Analyst Estimates for Novartis (NVS) Q1 Earnings, Beyond Revenue and EPS

2 High-Yield Dividend Stocks to Buy and Hold for 10 Years

Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades

Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug

Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact

Novartis (NVS) to Undertake Job Cuts in Development Department

Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says

Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population

Novartis (NVS) Stock Sinks As Market Gains: Here's Why

Novartis: Higher Guidance, Now A Buy

Novartis (NVS) Declines More Than Market: Some Information for Investors

The Magnificent 7 Of Dividend Aristocrats Yield As Much As 6%

Investors Heavily Search Novartis AG (NVS): Here is What You Need to Know

Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know

Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up

Novartis (NVS) Declines More Than Market: Some Information for Investors

Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund

Sanofi: My Top Pick In Big Pharma

1 Magnificent Dividend Stock to Buy and Hold

13 Dividend Aristocrat Bargains Yielding As Much As 9%

Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform

Novartis (NVS) Stock Dips While Market Gains: Key Facts

Bristol Myers Squibb cell therapy gets FDA green light to treat common type of leukemia

Here is What to Know Beyond Why Novartis AG (NVS) is a Trending Stock

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Ähnlich wie NVS